Loftus Peak Pty Ltd’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$58.3M Buy
50,391
+4,804
+11% +$5.67M 7.47% 3
2026
Q2
$54.7M Buy
+45,587
New +$46.6M 7.45% 3

Other funds holding LLY

Loftus Peak Pty Ltd's LLY Position: Q3 2026 in Review

Loftus Peak Pty Ltd increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $5.67M and bringing the position to 50,391 shares worth $58.3M. The position accounts for 7.47% of the portfolio, ranked #3.

Loftus Peak Pty Ltd first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. 637 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Loftus Peak Pty Ltd held 50,391 shares of Eli Lilly worth $58.3M as of Q3 2026.
  • Loftus Peak Pty Ltd bought 4,804 Eli Lilly shares in Q3 2026, an estimated $5.67M.
  • Eli Lilly made up 7.47% of Loftus Peak Pty Ltd's portfolio in Q3 2026, its #3 holding.
  • Loftus Peak Pty Ltd first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • 637 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Loftus Peak Pty Ltd's 13F filing for Q3 2026, filed 15 Oct 2026.